Adicet Bio, Inc. Common Stock (ACET) is a publicly traded Healthcare sector company. As of May 21, 2026, ACET trades at $7.95 with a market cap of $70.11M and a P/E ratio of -0.79. ACET moved +7.59% today. Year to date, ACET is -4.79%; over the trailing twelve months it is -35.28%. Its 52-week range spans $6.01 to $24.64. Analyst consensus is strong buy with an average price target of $34.83. Rallies surfaces ACET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Adicet Bio, Inc. Common Stock (ACET) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ACET moved +7.59% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $7.95 |
| Market Cap | $70.11M |
| P/E Ratio | -0.79 |
| EPS | $-9.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.64 |
| 52-Week Low | $6.01 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $682.93M |
| Net Income | $-346.15M |
| Gross Margin | 12.76% |
7 analysts cover ACET: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.83.